a:3:{s:6:"_token";s:40:"JtU2TvAnTbmSzb7X7dVf1luCpfVVrj4yNH4t5qaQ";s:9:"_previous";a:1:{s:3:"url";s:178:"https://www.pharmafocusasia.com/news/halozyme-announces-that-argenx-has-obtained-approval-in-japan-for-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-co-formulated-with-enhanze";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}